(Q46061243)

19 December 2017

title

An open pilot study of tiagabine in alcohol dependence: tolerability and clinical effects (English)

1 reference

19 December 2017

1 reference

T Paparrigopoulos

1

1 reference

19 December 2017

E Tzavellas

2

1 reference

19 December 2017

D Karaiskos

3

1 reference

19 December 2017

P Malitas

4

1 reference

19 December 2017

I Liappas

5

1 reference

19 December 2017

language of work or name

English

0 references

publication date

3 April 2009

1 reference

19 December 2017

Journal of Psychopharmacology

published in

1 reference

19 December 2017

volume

24

1 reference

19 December 2017

issue

9

1 reference

19 December 2017

page(s)

1375-1380

1 reference

19 December 2017

The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

Impact of craving on alcohol relapse during, and 12 months following, outpatient treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

Tiagabine does not attenuate alcohol-induced activation of the human reward system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

Using topiramate or naltrexone for the treatment of alcohol-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

Glutamatergic substrates of drug addiction and alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

Tiagabine increases cocaine‐free urines in cocaine‐dependent methadone‐treated patients: results of a randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

Inpatient desire to drink as a predictor of relapse to alcohol use following treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

Topiramate for treating alcohol dependence: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

Tiagabine: absence of kinetic or dynamic interactions with ethanol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

Mirtazapine improves alcohol detoxification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

Impact of alcohol detoxification on anxiety and depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

Amisulpride may help alcoholics in the early postdetoxification phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

GABA(A) receptors and alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

Efficacy and safety of pregabalin in alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

Tiagabine reduces ethanol reward in C57BL/6 mice under acute and chronic administration regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

From the neurobiologic basis of alcohol dependency to pharmacologic treatment strategies: bridging the knowledge gap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

Neuropharmacology of alcohol addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

Anxiety as a predictor of relapse in detoxified alcohol-dependent patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

The Selective GABA Reuptake Inhibitor Tiagabine for the Treatment of Generalized Anxiety Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109103799

21 January 2018

Identifiers

DOI

10.1177/0269881109103799

1 reference

19 December 2017

1 reference

19 December 2017